Name: Name:1-Piperazinamine, N-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-
Brand: AABLOCKS
SKU: AA0030A0
Rating: 90 (10 reviews)

Catalog No.: AA0030A0

304909-07-7 | 1-Piperazinamine, N-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-

Pack Size： 1mg

Purity： 98%

in stock

$10.00 $7.00

Pack Size： 5mg

Purity： 98%

in stock

$22.00 $16.00

Pack Size： 10mg

Purity： 98%

in stock

$32.00 $23.00

Pack Size： 25mg

Purity： 98%

in stock

$52.00 $37.00

Pack Size： 50mg

Purity： 98%

in stock

$89.00 $62.00

Pack Size： 100mg

Purity： 98%

in stock

$169.00 $118.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA0030A0

Chemical Name: 1-Piperazinamine, N-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-

CAS Number: 304909-07-7

Molecular Formula: C23H27N5

Molecular Weight: 373.4940

MDL Number: MFCD01827306

SMILES: Cc1nn(c(c1C=NN1CCN(CC1)Cc1ccccc1)C)c1ccccc1

NSC Number: 731871

Properties

Complexity: 489

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 1

Formal Charge: 0

Heavy Atom Count: 28

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 5

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 4.2

Downstream Synthesis Route

304909-07-7

14(C)SANT-1

[1]Zhang,Yinsheng;Stolle,WayneT.[Journaloflabelledcompoundsandradiopharmaceuticals,2010,vol.53,#5-6,p.487-489]

304909-07-7

3(H)SANT-1

[1]Locationinpatent:schemeortableZhang,Yinsheng;Stolle,WayneT.[Journaloflabelledcompoundsandradiopharmaceuticals,2010,vol.53,#5-6,p.487-489]

304909-07-7

3,5-dimethyl-1-(2-(3)H-phenyl)-1H-pyrazole-4-carbaldehyde

[1]Zhang,Yinsheng;Stolle,WayneT.[Journaloflabelledcompoundsandradiopharmaceuticals,2010,vol.53,#5-6,p.487-489]

304909-07-7

39139-52-1

[1]Zhang,Yinsheng;Stolle,WayneT.[Journaloflabelledcompoundsandradiopharmaceuticals,2010,vol.53,#5-6,p.487-489]

Literature fold

Title: Smoothened antagonists for hair inhibition.

Journal: Bioorganic & medicinal chemistry letters20100815

Title: Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.

Journal: Bioorganic & medicinal chemistry letters20100101

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry20020419

Building Blocks More >

3060-46-6

N-Methyl-L-leucine

AA0030KR | MFCD00065919

306936-30-1

Ethyl 5-(4-chlorophenyl)-4-(chlorosulfonyl)-2-methylfuran-3-carboxylate

AA0030TS | MFCD01934803

3074-46-2

1-Benzyl-4-phenylpiperazine

AA003114 | MFCD00811058

3085-54-9

p-Methylformanilide

AA0031FC | MFCD00014124

3098-18-8

2-Hydroxy-4-methylbenzophenone

AA0031QU | MFCD01099035

3109-99-7

2-Fluoro-2-methylpropan-1-ol

AA00321F | MFCD09030962

6942-99-0

2,4-dibromo-1,3,5-trimethylBenzene

AA00326F | MFCD00013525

98760-08-8

(2R,3S)-3-(t-BOC)amino-1,2-epoxy-4-phenylbutane

AA00329H | MFCD00671705

163765-44-4

(R)-4-N-Boc-2-methylpiperazine

AA0032CH | MFCD02683205

61607-68-9

1-(2-Dimethylaminoethyl)-5-mercapto-1,2,3,4-tetrazole

AA0032FM | MFCD00082923